[Ergospirometric studies on patients with diabetes mellitus and the effect of biguanides on physical performance]

Area of Science:

• Exercise physiology
• Pharmacology
• Metabolic disorders

Background:

• Diabetes mellitus is a metabolic disorder characterized by hyperglycemia.
• Exercise capacity is a crucial indicator of cardiovascular health and metabolic function.
• Biguanides are a class of oral antihyperglycemic agents commonly used in type 2 diabetes management.

Purpose of the Study:

• To investigate the impact of biguanide treatment on exercise capacity in diabetic patients.
• To explore the underlying physiological mechanisms, specifically energy production pathways, affected by biguanide therapy.

Main Methods:

• Submaximal exercise testing was conducted on 24 diabetic patients.
• Testing was performed before and four days after the initiation of biguanide treatment.
• Analysis focused on changes in exercise capacity and inferred energy production mechanisms.

Main Results:

• Biguanide treatment led to a statistically significant decrease in exercise capacity.
• The observed reduction in performance was associated with an increase in anaerobic energy production.
• This suggests a shift in the body's primary energy source during exercise post-treatment.

Conclusions:

• Biguanide therapy can negatively affect exercise performance in diabetic individuals.
• Increased reliance on anaerobic metabolism appears to be the mechanism behind this decline.
• Further research is warranted to optimize biguanide use while preserving physical function.